UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.
The psychedelic integration scales: Tools for measuring psychedelic integration behaviors and experiences
In this study, we describe the development and initial validation of two psychometric scales for measuring psychedelic integration.
The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955 – 2021) and recommendations for the field
We review data related to expectation and placebo effects, but argue that claims that microdosing effects are largely due to expectancy are premature and possibly wrong.
Psychedelics and psychotherapy: Cognitive-behavioral approaches as default
There are many sources from which psychedelic psychotherapy could draw, we argue that current gold-standard, evidence-based psychotherapeutic paradigms provide the best starting point.
LSD for anxiety and ketamine for behavioural addictions - 2 new drug company announcements
Early positive results released on LSD for anxiety and Ketamine for behavioural addictions.
Views on using psychoactive substances to self-manage functional neurological disorder: Online patient survey results
Further research exploring novel treatment options, such as psychedelics, in FND may be warranted.
Psychedelics as potential catalysts of scientific creativity and insight
While research in this area is limited, further work to elucidate how psychedelics may best contribute to scientific creativity enhancement is warranted.
Ministry of the mushroom: Psilocybin churches, psychedelic experience and sacred sensemaking
Different psilocybin churches may be united by this common process of sacred sensemaking.
Toward a new science of psychedelic social psychology: The effects of MDMA (ecstasy) on social connection
Improved relationships, reduced loneliness, stronger therapeutic alliances.
Sober sitter or coconsumer? Psychedelics, online forums and preferences for interpersonal interactions
There was disparity between consumer preferences and guidelines ... concerning consumer agency; consumption alongside others, and carers who had consumed psychedelics themselves.
Psychedelic mystical experience: A new agenda for theology
Religious leaders are beginning to speak out publicly in support of careful use of these drugs, and some are training to become “psychedelic chaplains” to work alongside mental health professionals administering these drugs.
Toward synergies of ketamine and psychotherapy
We review historical and modern approaches to the use of ketamine with psychotherapy.
COMP360 psilocybin therapy shows potential in exploratory open-label studies for anorexia nervosa and severe treatment-resistant depression
Positive data demonstrating the potential of psilocybin therapy in anorexia nervosa and severe treatment-resistant depression.
How important Is a guide who has taken psilocybin in psilocybin-assisted therapy for depression?
This is an interesting study exploring the ongoing question how important it is for psychedelic guides to have had their own personal experience of these medicines.
What’s the best psychedelic therapy protocol? It’s debatable
What will psychedelic-assisted therapy look like when it becomes available? This is a hot debate within the psychedelics field.
Using a MDMA- and LSD-group therapy model in clinical practice in Switzerland and highlighting the treatment of trauma-related disorders
The majority of the patients taking part in the psychedelic group therapy suffered from chronic complex post-traumatic stress disorder